相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma - A retrospective analysis of response and survival in patients treated in the Surgery Branch at the National Cancer Institute between 1986 and 2006
Jacob A. Klapper et al.
CANCER (2008)
Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2
Bianca Heemskerk et al.
HUMAN GENE THERAPY (2008)
IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation
Erwan Mortier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Preassociation of IL-15 with IL-15Rα-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action
Sigrid Dubois et al.
JOURNAL OF IMMUNOLOGY (2008)
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
Ruth R. French et al.
BLOOD (2007)
被撤回的出版物: Soluble interleukin (IL)-15Rα is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15 (Retracted Article. See vol 286, pg 5934, 2011)
Elena Bulanova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The IL-15/IL-15Rα on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells
Noriko Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A. Waldmann
NATURE REVIEWS IMMUNOLOGY (2006)
Converting IL-15 to a superagonist by binding to soluble IL-15Rα
Mark P. Rubinstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Eradication of established tumors in mice by a combination antibody-based therapy
Tomoyasu Uno et al.
NATURE MEDICINE (2006)
Synergistic activation of macrophages via CD40 and TLR9 results in T cell independent antitumor effects
IN Buhtoiarov et al.
JOURNAL OF IMMUNOLOGY (2006)
A function for interleukin 2 in Foxp3-expressing regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling
LM D'Cruz et al.
NATURE IMMUNOLOGY (2005)
Survival adjustment of mature dendritic cells by IL-15
SP Dubois et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance
H Kobayashi et al.
BLOOD (2005)
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
R Zeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cutting edge:: Murine dendritic cells require IL-15Rα to prime NK cells
R Koka et al.
JOURNAL OF IMMUNOLOGY (2004)
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs
G Ferlazzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma
J Honeychurch et al.
BLOOD (2003)
What does it take to make a natural killer?
F Colucci et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2:: Coordination of dendritic and CD8+ cell responses
WJ Murphy et al.
JOURNAL OF IMMUNOLOGY (2003)
IL-15Rα recycles and presents IL-15 in trans to neighboring cells
S Dubois et al.
IMMUNITY (2002)
Interleukin-2 and interleukin-15: immunotherapy for cancer
TA Fehniger et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
T cell-independent interleukin 15Rα signals are required for bystander proliferation
JP Lodolce et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Anti-CD40 antibody induces antitumor and antimetastatic effects: The role of NK cells
JG Turner et al.
JOURNAL OF IMMUNOLOGY (2001)
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
J Marks-Konczalik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
MK Kennedy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Control of homeostasis of CD8+ memory T cells by opposing cytokines
CC Ku et al.
SCIENCE (2000)
分享论文
